一项重大研究发现，大多数成功消融的心房颤动患者可以安全地停止长期使用血液稀释剂。 A major study finds most atrial fibrillation patients with successful ablation can safely stop long-term blood thinners.

一项由加拿大研究人员共同领导的大型国际研究发现，许多成功消融手术的心房颤动患者可以安全地停止长期使用血液稀释剂。 A large international study co-led by Canadian researchers finds that many atrial fibrillation patients with successful ablation procedures may safely stop long-term blood thinners. 经过三年,里瓦洛克萨班和低剂量阿司匹林患者中,中风和血栓发生率相似,脑磁共振显示静音中风发生率非常低,96% 的患者没有症状. After three years, stroke and embolism rates were similar between those on rivaroxaban and those on low-dose aspirin, with brain MRIs showing very low silent stroke rates—96% of patients had no signs. 研究人员说,血液不断稀释者的好处可能不会超过那些成功渗漏者流血的风险,有可能导致修订全球治疗准则。 Researchers say the benefits of continuing blood thinners may not outweigh bleeding risks for those with successful ablations, potentially leading to revised global treatment guidelines.